A Phase 2 interventional study of IV Methylprednisolone pulses in Neuroendocrine Cell Hyperplasia of Infancy, sponsored by Assistance Publique - Hôpitaux de Paris. Recruiting at 1 site in France. Open to participants aged Up to 12 Years. Per ClinicalTrials.gov, last updated 2025-08-27.
Sponsored by Assistance Publique - Hôpitaux de Paris · Phase 2, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Childhood interstitial lung diseases (chILD) are a heterogeneous group of rare and severe disorders with an estimated prevalence of 1/100,000. Among them, neuroendocrine cells hyperplasia of infancy (NEHI), also called persistent tachypnoea of infancy (PTI), is one of the most common aetiology (up to 16% of the cases). NEHI involves young infants (median age at onset 3 to 6 months) with tachypnoea, hypoxemia, crackles, retractions, failure to thrive and specific localizations of ground glass opacities (GGO) on chest CT-scan (paramediastinal areas and anterior lobes (right middle lobe and lingula). At diagnosis, most patients (50 to 100%) require oxygen supplementation that usually lasts for months to years, sometimes associated with nutritional support with eventual enteral nutrition. NEHI is believed to be related to an increased number of neuroendocrine cells in airway epithelial area. These cells are abundant in foetal life, when they play a role in regulating the lung development and decrease before birth.
There is no specific treatment for NEHI. The main treatment of chILD is corticosteroids. However, in NEHI, their efficacy is matter of debate. There is only a few NEHI cases series or cohorts all over the world, accounting for a maximum of 500 reported cases within only retrospective studies. Among them, United States and Argentina teams report supportive care only (oxygen therapy and nutritional support) whereas other teams, like the French ones largely uses IV corticosteroid pulses.
Unlike the majority of chILD, NEHI prognosis is usually good. However, at school-age, 26% of the patients remain symptomatic or have an abnormal lung function. Moreover, oxygen therapy significantly affects quality of life (QoL) of the children with ILD (-10.43/100 points, p=0.02) but also QoL and mood of their parents (unpublished data).
The present study hypothesis that corticosteroids are associated with a reduction of the length of oxygen support in infants with NEHI.
This study aims at assessing the beneficial effect of IV methylprednisolone pulses on oxygen therapy in infants with NEHI. It applies to all hypoxic NEHI patients aged below 12 months and followed in one of the centres of the RespiRare network. 18 patients will be recruited.
CORTICO-NEHI is designed as an early phase study following an A'Hern's Single Stage Phase II design.
All the patients are included in a single group receiving as a standard of care a maximum of 6 IV pulses of 3 days each.
12 visits will be performed as a standard of care:
For the research needs,
76 studies on the registry are indexed under Hyperplasia; 9 are open to participants now.
This study's planned enrollment of 18 is below the median of 60 across 51 interventional studies indexed under Hyperplasia.
Browse Hyperplasia studies →Assistance Publique - Hôpitaux de Paris is the lead sponsor of 3,598 studies on the registry; 1,038 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
NEHI diagnosis based on:
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A biopsy takes a small piece of tissue to examine. “Archival tissue” is a sample already taken, for example at diagnosis, and kept by the hospital.
Whether a stored sample will do depends on when it was taken, how much there is and what the study needs. Ask whether the study accepts your stored sample or needs a new biopsy.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Vaccines made with a weakened form of the germ, such as measles–mumps–rubella (MMR), chickenpox and yellow fever. They can be risky when the immune system is weakened. Flu injections are not live; the nasal flu spray is.
Biopsy and archival tissue
A biopsy takes a small piece of tissue to examine. “Archival tissue” is a sample already taken, for example at diagnosis, and kept by the hospital.
Whether a stored sample will do depends on when it was taken, how much there is and what the study needs. Ask whether the study accepts your stored sample or needs a new biopsy.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Live vaccines
Vaccines made with a weakened form of the germ, such as measles–mumps–rubella (MMR), chickenpox and yellow fever. They can be risky when the immune system is weakened. Flu injections are not live; the nasal flu spray is.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Drug: IV Methylprednisolone pulses
Six (6) pulses (max) are performed at a 4 weeks interval (+/- 10 days). Each pulse is a 3-days-6h-perfusions of Methylprednisolone (500mg and 120mg) 10mg/kg/day diluted in 50ml of saline under supervision of SpO2, heart rate, blood pressure /
Number of children still requiring oxygen therapy
To evaluate the efficacy on oxygen therapy need of a 6 months methylprednisolone pulses in NEHI patients at M18.
Time frame: Month 18
Time to achieve the oxygen therapy weaning
Duration between randomization and the absence of oxygen therapy requirement at M18
Time frame: Month 18
The number of patients requiring continuous oxygen therapy (meaning sleep and awake oxygen therapy by opposition to sleep oxygen only) over time
Number of children still requiring oxygen therapy/ Number of children requiring only sleep oxygen
Time frame: Month 18
The number of patients requiring only sleep oxygen over time
Number of children requiring only sleep oxygen
Time frame: Month 18
The number of patients with a normal respiratory rate
Number of children with a normal respiratory rate at rest
Time frame: Month 18
ChILD healing (reduction of severity) over time
Difference of Fan's severity score assessing the severity of children with ILD (respiratory symptoms, SpO2\<90% at sleep or exertion, SpO2\<90% at rest and pulmonary hypertension)
Time frame: Between Month 0 and Month 18
Parents QoL
Family impact PedsQL score and a parents QoL score (submitted for publication)
Time frame: Month 0 and Month 18
Patient's QoL
Patients impact PedsQL and the chILD QoL scores; the chILDPQoL score.
Time frame: Month 0 and Month 18
Impact of NEHI on feeding and growth status
Number of patients requiring at least one enteral nutrition episode (based on the physician appreciation in case of abnormal weight curve)
Time frame: Between Month 0 and Month 18
Safety of methylprednisolone pulses
Number of unexpected hospitalizations for a respiratory exacerbation
Time frame: Between Month 0 and Month 18
Number of antibiotic courses for an infectious lung exacerbation
Safety of methylprednisolone pulses
Time frame: Between Month 0 and Month 18
Safety of methylprednisolone pulses
* the number of patients with at least once systolic or diastolic arterial blood pressure (AP) over 2SD for the age at the days of methylprednisolone pulses * the number of patients with at least one elevated fasting glycaemia before the first day of methylprednisolone pulses.
Time frame: At Month 6
Safety of methylprednisolone pulses
\- the number of patients with at least one elevated fasting glycaemia before the first day of methylprednisolone pulses.
Time frame: At Month 6
To compare the family impact PedsQL questionnaire to the newly described chILD-PQoL questionnaire
Correlation between family impact PedsQL questionnaire and the newly described chILD-PQoL questionnaire
Time frame: Month 0, Month 6, Month 12, Month 18
To study thoracic CT-scan evolution
Number of patients with an extension, a stability, a decrease or an absence of the GGO lesions on the CT-scan
Time frame: at Month 6 and Month 18
Plan to share: Undecided
No publications or documents are linked to this record.
Started Jun 2025 (actual). Primary completion is estimated for Feb 2029, 43 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Assistance Publique - Hôpitaux de Paris →